RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
ANTIBIOTICS (BASEL, SWITZERLAND)
Collezione AOU Città della Salute di Torino

Items : 17

Epidemiology and Genetic Traits of Carbapenemase-Producing Enterobacterales: A Global Threat to Human Health. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2025 Feb 1;14(2):141. doi: 10.3390/antibiotics14020141.

2025
AOU Città della Salute di Torino

Alvisi G; Curtoni A; Fonnesu R; Piazza A; Signoretto C; Piccinini G; Sassera D; Gaibani P;

Helicobacter pylori in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander? in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2024 Mar 17;13(3):267. doi: 10.3390/antibiotics13030267.

2024
AOU Città della Salute di Torino

Bretto E; Frara S; Armandi A; Caviglia GP; Saracco GM; Bugianesi E; Pitoni D; Ribaldone DG;

Epidemiology and Impact of Anti-Pneumococcal Vaccination and COVID-19 on Resistance of Streptococcus pneumoniae Causing Invasive Disease in Piedmont, Italy. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2024 Aug 6;13(8):740. doi: 10.3390/antibiotics13080740.

2024
ASL Alessandria
AOU Città della Salute di Torino

Cavallo R; Charrier L; Zanotto E; Alizzi S; Casale R; Lombardi D; Barbui AM; Peradotto M; Curtoni A; Koumantakis E; Bondi A; Costa C;

Development and Validation of a Prognostic Model for Multi-Drug-Resistant Non-Hospital-Acquired Bloodstream Infection. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 May 24;12(6):955. doi: 10.3390/antibiotics12060955.

2023
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino

Montrucchio G; Lupia E; De Rosa FG; Ghisetti V; Cavallo R; Aprà F; Galmozzi M; Petitti P; Galli E; Brussino A; Capodanno A; Peasso P; Cara I; Pivetta E; Corcione S;

Disc Diffusion and ComASP(®) Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Mar 17;12(3):604. doi: 10.3390/antibiotics12030604.

2023
AOU Città della Salute di Torino

Bianco G; Boattini M; Comini S; Banche G; Cavallo R; Costa C;

Performance Evaluation of BD Phoenix and MicroScan WalkAway Plus for Determination of Fosfomycin Susceptibility in Enterobacterales. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Jun 26;12(7):1106. doi: 10.3390/antibiotics12071106.

2023
ASL Vercelli
AOU Città della Salute di Torino

Cavallo R; Barbui AM; Iannaccone M; Bianco G; Zanotto E; Boattini M; Curtoni A; Peradotto M; Bondi A; Costa C;

Impact of NG-Test CTX-M MULTI Immunochromatographic Assay on Antimicrobial Management of Escherichia coli Bloodstream Infections. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Feb 27;12(3):473. doi: 10.3390/antibiotics12030473.

2023
ASL Asti
AOU Città della Salute di Torino

De Rosa FG; Cavallo R; Corcione S; Comini S; Ghibaudo D; Bianco G; Boattini M; Costa C;

Multicentre Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) Extending Analysis to 16-20 Hours Reading Time. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2022 Oct 13;11(10):1404. doi: 10.3390/antibiotics11101404.

2022
AOU Città della Salute di Torino

Bianco G; Lombardo D; Ricciardelli G; Boattini M; Comini S; Cavallo R; Costa C; Ambretti S;

Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2022 Nov 22;11(12):1681. doi: 10.3390/antibiotics11121681.

2022
AOU Città della Salute di Torino

Bianco G; Gaibani P; Comini S; Boattini M; Banche G; Costa C; Cavallo R; Nordmann P;

An Observational Study of MDR Hospital-Acquired Infections and Antibiotic Use during COVID-19 Pandemic: A Call for Antimicrobial Stewardship Programs. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2022 May 20;11(5):695. doi: 10.3390/antibiotics11050695.

2022
AOU Città della Salute di Torino

Shbaklo N; Corcione S; Vicentini C; Giordano S; Fiorentino D; Bianco G; Cattel F; Cavallo R; Zotti CM; De Rosa FG;

Effect of Fluoroquinolone Use in Primary Care on the Development and Gradual Decay of Escherichia coli Resistance to Fluoroquinolones: A Matched Case-Control Study. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2022 Jun 18;11(6):822. doi: 10.3390/antibiotics11060822.

2022
AOU Città della Salute di Torino

Kurotschka PK; Fulgenzio C; Da Cas R; Traversa G; Ferrante G; Massidda O; Gágyor I; Aschbacher R; Moser V; Pagani E; Spila Alegiani S; Massari M;

Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2022 Dec 16;11(12):1830. doi: 10.3390/antibiotics11121830.

2022
ASL Asti
ASL Città di Torino
AOU Città della Salute di Torino

De Rosa FG; Di Perri G; D'Avolio A; Mula J; Lupia T; Vita D; De Benedetto I; Scabini S; De Nicolò A; Montrucchio G; Mornese Pinna S; Corcione S;

Enhanced Antimicrobial and Antibiofilm Effect of New Colistin-Loaded Human Albumin Nanoparticles. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2021 Jan 8;10(1):57. doi: 10.3390/antibiotics10010057.

2021
AOU Città della Salute di Torino

Scutera S; Argenziano M; Sparti R; Bessone F; Bianco G; Bastiancich C; Castagnoli C; Stella M; Musso T; Cavalli R;

The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg). in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2021 Aug 11;10(8):965. doi: 10.3390/antibiotics10080965.

2021
AOU Città della Salute di Torino

Caldas M; Pérez-Aisa Á; Tepes B; Keco-Huerga A; Bujanda L; Lucendo AJ; Rodrigo L; Vaira D; Fernández-Salazar L; Huguet JM; Pérez-Lasala J; Jurecic NB; Fadeenko G; Barrio J; Areia M; Ortuño J; Pellicano R; Leja M; Molina-Infante J; Bogomolov P; Alekseenko S; Domínguez-Cajal M; Gómez-Camarero J; Ntouli V; Martínez-Domínguez SJ; Ruiz-Zorrilla R; Núñez O; Sarsenbaeva AS; Almela P; et alii...

Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2021 Apr 16;10(4):451. doi: 10.3390/antibiotics10040451.

2021
AOU Città della Salute di Torino

Fulgenzio C; Massari M; Traversa G; Da Cas R; Ferrante G; Aschbacher R; Moser V; Pagani E; Vestri AR; Massidda O; Kurotschka PK;

Antibiotic Resistance and Therapy Outcome in H. pylori Eradication Failure Patients. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2020 Mar 13;9(3):121. doi: 10.3390/antibiotics9030121.

2020
AOU Città della Salute di Torino

Saracino IM; Pavoni M; Zullo A; Fiorini G; Saccomanno L; Lazzarotto T; Cavallo R; Antonelli G; Vaira D;

Sepsis and Nosocomial Infections: The Role of Medico-Legal Experts in Italy. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2019 Oct 28;8(4):199. doi: 10.3390/antibiotics8040199.

2019
AOU Città della Salute di Torino

Tattoli L; Dell'Erba A; Ferorelli D; Gasbarro A; Solarino B;